Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin α5β1, also known as the fibronectin receptor or VLA-5, is a transmembrane heterodimeric protein composed of alpha 5 (ITGA5/CD49e) and beta 1 (ITGB1/CD29) subunits. It is a primary cellular receptor for fibronectin, an essential extracellular matrix (ECM) glycoprotein. It plays critical roles in cell adhesion, migration, and angiogenesis, and is often overexpressed in tumors and tumor vasculature, making it a potential therapeutic target.
Blocking ligand binding; Disrupting downstream signaling pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin α5β1 (α5β1).